ZA963433B - Presentation of bioactives - Google Patents

- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

ZA963433A1995-05-011996-04-30Presentation of bioactivesZA963433B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9508823.3AGB9508823D0 (en)	1995-05-01	1995-05-01	Drug Derivatives

Publication Number	Publication Date
ZA963433Btrue ZA963433B (en)	1996-08-07

Application Number	Title	Priority Date	Filing Date
ZA963360AZA963360B (en)	1995-05-01	1996-04-26	Presentation of bioactives
ZA963397AZA963397B (en)	1995-05-01	1996-04-29	Esters and pharmaceutical compositions
ZA963433AZA963433B (en)	1995-05-01	1996-04-30	Presentation of bioactives

Application Number	Title	Priority Date	Filing Date
ZA963360AZA963360B (en)	1995-05-01	1996-04-26	Presentation of bioactives
ZA963397AZA963397B (en)	1995-05-01	1996-04-29	Esters and pharmaceutical compositions

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5919815A (en)*	1996-05-22	1999-07-06	Neuromedica, Inc.	Taxane compounds and compositions
US5994392A (en)*	1988-02-26	1999-11-30	Neuromedica, Inc.	Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US6080877A (en)*	1996-05-22	2000-06-27	Neuromedica, Inc.	Taxanes
US6225444B1 (en)	1998-02-10	2001-05-01	Protarga, Inc.	Neuroprotective peptides and uses thereof

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2252874T3 (en)*	1997-12-12	2006-05-16	Purdue Research Foundation	USE OF CONJUGATED LINOLEIC ACID FOR TREATMENT OF MELLITUS TYPE II DIABETES.
US7015249B1 (en)	1997-12-12	2006-03-21	Purdue Research Foundation	Methods and compositions for treating diabetes
JP2003520846A (en)*	2000-01-28	2003-07-08	ザプロクターアンドギャンブルカンパニー	Tasty arginine compounds for cardiovascular health and uses thereof
US8288369B2 (en)*	2006-06-27	2012-10-16	University Of South Florida	Delta-tocotrienol treatment and prevention of pancreatic cancer
CN102260178A (en)*	2010-05-25	2011-11-30	中国医学科学院药物研究所	Hydroxyl propanediol derivative, its preparation method, its pharmaceutical composition and its purpose
CN102260177A (en)*	2010-05-25	2011-11-30	中国医学科学院药物研究所	Propylene glycol derivative, preparation method thereof, pharmaceutical composition thereof and application thereof
WO2013166176A1 (en)*	2012-05-01	2013-11-07	Catabasis Pharmaceuticals, Inc.	Fatty acid conjugates of statin and fxr agonists; compositions and method of uses
CN106957307B (en)*	2017-03-27	2019-06-28	淮阴工学院	A kind of dantrolene sodium derivative and preparation method thereof

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5994392A (en)*	1988-02-26	1999-11-30	Neuromedica, Inc.	Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US6258836B1 (en)	1988-02-26	2001-07-10	Protarga, Inc.	Dopamine analog amide
US6407137B2 (en)	1988-02-26	2002-06-18	Protarga, Inc.	Dopamine analog amide
US5919815A (en)*	1996-05-22	1999-07-06	Neuromedica, Inc.	Taxane compounds and compositions
US6080877A (en)*	1996-05-22	2000-06-27	Neuromedica, Inc.	Taxanes
US6225444B1 (en)	1998-02-10	2001-05-01	Protarga, Inc.	Neuroprotective peptides and uses thereof
US6627601B2 (en)	1998-02-10	2003-09-30	Protarga, Inc.	Neuroprotective peptides and uses thereof

Publication	Publication Date	Title
GB9622636D0 (en)	1997-01-08	Presentation of bioactives
PL322277A1 (en)	1998-01-19	Derivatives of pyrazol-4-ylobenzoyl
PL327569A1 (en)	1998-12-21	Promedications of thrombosin inhibitors
GB9526560D0 (en)	1996-02-28	Use of 2-Amino-Heterocycles
PL324451A1 (en)	1998-05-25	Derivatives of diphenylmethylenepiperidine
GB9512290D0 (en)	1995-08-16	Uses of polyhexanide
IL122607A0 (en)	1998-08-16	Preparation of N-substituted 3-hydroxypyrazoles
IL116924A (en)	2001-01-28	Preparation of n-aryl - and n-hetarylhydroxylamines
ZA963360B (en)	1996-08-20	Presentation of bioactives
SG42329A1 (en)	1997-08-15	Use of phenylcyclohexylcarboxamides
IL112924A0 (en)	1995-06-29	Easel
IL113228A (en)	1999-09-22	Derivatives of anandamide
HRP960395B1 (en)	2001-12-31	Zwitterionic forms of trovafloxacin
GB9410153D0 (en)	1994-07-06	Presentation of packages
PL323148A1 (en)	1998-03-16	Esters of crabapenemes
IL117786A (en)	2000-07-16	Preparation of alpha-bisoximes
ZA968873B (en)	1997-05-28	Isomerisation of equillin
HUT76555A (en)	1997-09-29	Derivatives of trans apovincaminic-acid-esters
NZ307236A (en)	1998-12-23	Preparation of streptogramins
GB9622347D0 (en)	1997-01-08	Presentation of bioactives
PL323141A1 (en)	1998-03-16	Esters of crabapenemes
GB9605440D0 (en)	1996-05-15	Presentaion of bioactives
ZA962440B (en)	1996-10-01	Destressing of railtracks
GB9500685D0 (en)	1995-03-08	Preparation of esters
GB9501619D0 (en)	1995-03-15	Preparation of esters